Nuclear monomeric integrin αv in cancer cells is a coactivator regulated by thyroid hormone

FASEB Journal

Volumn 27, Issue 8, 2013, Pages 3209-3216

  Lin, Hung Yun ^a   Su, Yee Fun ^a   Hsieh, Meng Ti ^a   Lin, Sharon ^b   Meng, Ran ^b   London, David ^b   Lin, Cassie ^b   Tang, Heng Yuan ^b   Hwang, Jaulang ^c   Davis, Faith B ^b   Mousa, Shaker A ^b   Davis, Paul J ^b,d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Angiogenesis; Carcinogenesis; Gene expression; Thyroxine

Indexed keywords

BETA3 INTEGRIN; CD51 ANTIGEN; COREPRESSOR PROTEIN; CYCLOOXYGENASE 2; ESTROGEN RECEPTOR ALPHA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MONOMER; STAT1 PROTEIN; THYROID HORMONE; THYROID HORMONE RECEPTOR BETA; THYROXINE; ALPHA5 INTEGRIN; HISTONE ACETYLTRANSFERASE PCAF; LIOTHYRONINE; MAPK1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BINDING; STAT1 PROTEIN, HUMAN; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CARCINOGENESIS; CELL FRACTIONATION; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOPRECIPITATION; IN VITRO STUDY; INTERNALIZATION; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; ACTIVE TRANSPORT; CELL NUCLEUS; CHEMISTRY; DRUG EFFECTS; ENDOCYTOSIS; GENETICS; IMMUNOBLOTTING; METABOLISM; NEOPLASM; PATHOLOGY; PHOSPHORYLATION; PROMOTER REGION; PROTEIN MULTIMERIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL LINE, TUMOR; CELL NUCLEUS; CYCLOOXYGENASE 2; ENDOCYTOSIS; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOBLOTTING; INTEGRIN ALPHA5; INTEGRIN ALPHAVBETA3; INTEGRIN BETA3; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASMS; P300-CBP TRANSCRIPTION FACTORS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN MULTIMERIZATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAT1 TRANSCRIPTION FACTOR; THYROID HORMONES; THYROXINE; TRIIODOTHYRONINE;

EID: 84881171782     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-227132     Document Type: Article

References (53)

1. Cabodi, S., del Pilar Camacho-Leal, M., Di Stefano, P., and Defilippi, P. (2010) Integrin signalling adaptors: not only figurants in the cancer story. Nat. Rev. Cancer 10, 858-870
2. Arnaout, M. A., Goodman, S. L., and Xiong, J.-P. (2007) Structure and mechanics of integrin-based cell adhesion. Curr. Opin. Cell Biol. 19, 495-507
3. Byzova, T. V., Goldman, C. K., Pampori, N., Thomas, K. A., Bett, A., Shattil, S. J., and Plow, E. F. (2000) A mechanism for modulation of cellular responses to VEGF: activation of the integrins. Mol. Cell 6, 851-860
4. Desgrosellier, J. S., and Cheresh, D. A. (2010) Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer 10, 9-22
5. Bergh, J. J., Lin, H.-Y., Lansing, L., Mohamed, S. N., Davis, F. B., Mousa, S., and Davis, P. J. (2005) Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 146, 2864-2871
6. Lin, H.-Y., Sun, M., Lin, C., Tang, H.-Y., London, D., Shih, A., Davis, F. B., and Davis, P. J. (2009) Androgen-induced human breast cancer cell proliferation is mediated by discrete mechanisms in estrogen receptor-alpha-positive and-negative breast cancer cells. J. Steroid Biochem. Mol. Biol. 113, 182-188
7. Lin, H.-Y., Lansing, L., Merillon, J.-M., Davis, F. B., Tang, H.-Y., Shih, A., Vitrac, X., Krisa, S., Keating, T., Cao, H. J., Bergh, J., Quackenbush, S., and Davis, P. J. (2006) Integrin alphaVbeta3 contains a receptor site for resveratrol. FASEB J. 20, 1742-1744
8. Davis, F. B., Tang, H.-Y., Shih, A., Keating, T., Lansing, L., Hercbergs, A., Fenstermaker, R. A., Mousa, A., Mousa, S. A., Davis, P. J., and Lin, H.-Y. (2006) Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells. Cancer Res. 66, 7270-7275
9. Lin, H.-Y., Sun, M., Tang, H.-Y., Lin, C., Luidens, M. K., Mousa, S. A., Incerpi, S., Drusano, G. L., Davis, F. B., and Davis, P. J. (2009) l-Thyroxine vs. 3,5,3=-triiodo-l-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Am. J. Physiol. Cell Physiol. 296, 980-991
10. Lin, H.-Y., Tang, H.-Y., Keating, T., Wu, Y.-H., Shih, A., Hammond, D., Sun, M., Hercbergs, A., Davis, F. B., and Davis, P. J. (2008) Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin and ERK mediated. Carcinogenesis 29, 62-69
11. Lin, H.-Y., Tang, H.-Y., Shih, A., Keating, T., Cao, G., Davis, P. J., and Davis, F. B. (2007) Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic. Steroids 72, 180-187
12. Meng, R., Tang, H.-Y., Westfall, J., London, D., Cao, J. H., Mousa, S. A., Luidens, M., Hercbergs, A., Davis, F. B., Davis, P. J., and Lin, H.-Y. (2011) Crosstalk between integrin v-3 and estrogen receptor-is involved in thyroid hormone-induced proliferation in human lung carcinoma cells. PLoS One 6, e27547
13. Davis, P. J., Davis, F. B., Mousa, S. A., Luidens, M. K., and Lin, H.-Y. (2011) Membrane receptor for thyroid hormone: physiologic and pharmacologic implications. Annu. Rev. Pharmacol. Toxicol. 51, 99-9115
14. Lin, H.-Y., Cody, V., Davis, F. B., Hercbergs, A. A., Luidens, M. K., Mousa, S. A., and Davis, P. J. (2011) Identification and functions of the plasma membrane receptor for thyroid hormone analogues. Discov. Med. 11, 337-347
15. D'Arezzo, S., Incerpi, S., Davis, F. B., Acconcia, F., Marino, M., Farias, R. N., and Davis, P. J. (2004) Rapid nongenomic effects of 3,5,3=-triiodo-l-thyronine on the intracellular pH of L-6 myoblasts are mediated by intracellular calcium mobilization and kinase pathways. Endocrinology 145, 5694-5703
16. Lin, H.-Y., Tang, H. Y., Davis, F. B., Mousa, S. A., Incerpi, S., Luidens, M. K., Meng, R., and Davis, P. J. (2012) Nongenomic regulation by thyroid hormone of plasma membrane ion and small molecule pumps. Discov. Med. 14, 199-206
17. Yonkers, M. A., and Ribera, A. B. (2009) Molecular components underlying nongenomic thyroid hormone signaling in embryonic zebrafish neurons. Neural Dev. 4, 20-20
18. Cao, H. J., Lin, H.-Y., Luidens, M. K., Davis, F. B., and Davis, P. J. (2009) Cytoplasm-to-nucleus shuttling of thyroid hormone receptor-beta1 (Trbeta1) is directed from a plasma membrane integrin receptor by thyroid hormone. Endocr. Res. 34, 31-42
19. Tang, H.-Y., Lin, H.-Y., Zhang, S., Davis, F. B., and Davis, P. J. (2004) Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor. Endocrinology 145, 3265-3272
20. Roberts, M. S., Woods, A. J., Dale, T. C., Van Der Sluijs, P., and Norman, J. C. (2004) Protein kinase B/Akt acts via glycogen synthase kinase 3 to regulate recycling of alpha v beta 3 and alpha 5 beta 1 integrins. Mol. Cell. Biol. 24, 1505-1515
21. Shih, A., Lin, H. Y., Davis, F. B., and Davis, P. J. (2001) Thyroid hormone promotes serine phosphorylation of p53 by mitogenactivated protein kinase. Biochemistry 40, 2870-2878
22. Tang, H.-Y., Shih, A., Cao, H. J., Davis, F. B., Davis, P. J., and Lin, H.-Y. (2006) Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells. Mol. Cancer Ther. 5, 2034-2042
23. Cody, V., Davis, P. J., and Davis, F. B. (2007) Molecular modeling of the thyroid hormone interactions with alpha v beta 3 integrin. Steroids 72, 165-170
24. Davis, P. J., Shih, A., Lin, H. Y., Martino, L. J., and Davis, F. B. (2000) Thyroxine promotes association of mitogen-activated protein kinase and nuclear thyroid hormone receptor (TR) and causes serine phosphorylation of TR. J. Biol. Chem. 275, 38032-38039
25. Lin, H. Y., Davis, F. B., Gordinier, J. K., Martino, L. J., and Davis, P. J. (1999) Thyroid hormone induces activation of mitogenactivated protein kinase in cultured cells. Am. J. Physiol. Cell Physiol. 276, 1014-1024
26. Mousa, S. A., Davis, F. B., Mohamed, S., Davis, P. J., and Feng, X. (2006) Pro-angiogenesis action of thyroid hormone and analogs in a three-dimensional in vitro microvascular endothelial sprouting model. Int. Angiol. 25, 407-413
27. Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., Metzger, D., and Chambon, P. (1995) Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270, 1491-1494
28. Cheng, S.-Y., Leonard, J. L., and Davis, P. J. (2010) Molecular aspects of thyroid hormone actions. Endocr. Rev. 31, 139-170
29. Lazar, M. A. (2003) Nuclear receptor corepressors. Nucl. Recept. Signal. 1, e001
30. Varlakhanova, N., Hahm, J. B., and Privalsky, M. L. (2011) Regulation of SMRT corepressor dimerization and composition by MAP kinase phosphorylation. Mol. Cell. Endocrinol. 332, 180-188
31. Watson, P. J., Fairall, L., and Schwabe, J. W. R. (2012) Nuclear hormone receptor co-repressors: structure and function. Mol. Cell. Endocrinol. 348, 440-449
32. Wojciak, J. M., Martinez-Yamout, M. A., Dyson, H. J., and Wright, P. E. (2009) Structural basis for recruitment of CBP/ p300 coactivators by STAT1 and STAT2 transactivation domains. EMBO J. 28, 948-958
33. Glinskii, A. B., Glinsky, G. V., Lin, H.-Y., Tang, H.-Y., Sun, M., Davis, F. B., Luidens, M. K., Mousa, S. A., Hercbergs, A. H., and Davis, P. J. (2009) Modification of survival pathway gene expression in human breast cancer cells by tetraiodothyroacetic acid (tetrac). Cell Cycle 8, 3554-3562
34. Yalcin, M., Dyskin, E., Lansing, L., Bharali, D. J., Mousa, S. S., Bridoux, A., Hercbergs, A. H., Lin, H. Y., Davis, F. B., Glinsky, G. V., Glinskii, A., Ma, J., Davis, P. J., and Mousa, S. A. (2010) Tetraiodothyroacetic acid (tetrac) and nanoparticulate tetrac arrest growth of medullary carcinoma of the thyroid. J. Clin. Endocrinol. Metab. 95, 1972-1980
35. Beber, E. H., Capelo, L. P., Fonseca, T. L., Costa, C. C., Lotfi, C. F., Scanlan, T. S., and Gouveia, C. H. A. (2009) The thyroid hormone receptor (TR) beta-selective agonist GC-1 inhibits proliferation but induces differentiation and TR beta mRNA expression in mouse and rat osteoblast-like cells. Calcif. Tissue Int. 84, 324-333
36. Moeller, L. C., Dumitrescu, A. M., and Refetoff, S. (2005) Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1alpha and glycolytic genes. Mol. Endocrinol. 19, 2955-2963
37. Rae, M. T., Gubbay, O., Kostogiannou, A., Price, D., Critchley, H. O. D., and Hillier, S. G. (2007) Thyroid hormone signaling in human ovarian surface epithelial cells. J. Clin. Endocrinol. Metab. 92, 322-327
38. Cannistra, S. A., Ottensmeier, C., Niloff, J., Orta, B., and DiCarlo, J. (1995) Expression and function of beta 1 and alpha v beta 3 integrins in ovarian cancer. Gynecol. Oncol. 58, 216-225
39. Dijkgraaf, I., Kruijtzer, J. A., Frielink, C., Corstens, F. H., Oyen, W. J., Liskamp, R. M., and Boerman, O. C. (2007) Alpha v beta 3 integrin-targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide. Int. J. Cancer 120, 605-610
40. Odrljin, T. M., Haidaris, C. G., Lerner, N. B., and Simpson-Haidaris, P. J. (2001) Integrin alphavbeta3-mediated endocytosis of immobilized fibrinogen by A549 lung alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 24, 12-21
41. Leonard, J. L., and Farwell, A. P. (1997) Thyroid hormoneregulated actin polymerization in brain. Thyroid 7, 147-151
42. Davis, F. B., Mousa, S. A., O'Connor, L., Mohamed, S., Lin, H.-Y., Cao, H. J., and Davis, P. J. (2004) Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface. Circ. Res. 94, 1500-1506
43. Mousa, S. S., Davis, F. B., Davis, P. J., and Mousa, S. A. (2010) Human platelet aggregation and degranulation is induced in vitro by l-thyroxine, but not by 3,5,3=-triiodo-l-thyronine or diiodothyropropionic acid (DITPA). Clin. Appl. Thromb. Hemost. 16, 288-293
44. Visser, W. E., Friesema, E. C. H., and Visser, T. J. (2011) Minireview: thyroid hormone transporters: the knowns and the unknowns. Mol. Endocrinol. 25, 1-14
45. Riis, A. L. D., Jorgensen, J. O. L., Ivarsen, P., Frystyk, J., Weeke, J., and Moller, N. (2008) Increased protein turnover and proteolysis is an early and primary feature of short-term experimental hyperthyroidism in healthy women. J. Clin. Endocrinol. Metab. 93, 3999-4005
46. Furuya, F., Guigon, C. J., Zhao, L., Lu, C., Hanover, J. A., and Cheng, S. Y. (2007) Nuclear receptor corepressor is a novel regulator of phosphatidylinositol 3-kinase signaling. Mol. Cell. Biol. 27, 6116-6126
47. Jang, E. R., Choi, J. D., Jeong, G., and Lee, J.-S. (2010) Phosphorylation of p300 by ATM controls the stability of NB S1. Biochem. Biophys. Res. Commun. 397, 637-643
48. Lim, J.-Y., Oh, M.-A., Kim, W. H., Sohn, H.-Y., and Park, S. I. (2012) AMP-activated protein kinase inhibits TGF-induced fibrogenic responses of hepatic stellate cells by targeting transcriptional coactivator p300. J. Cell Physiol. 227, 1081-1089
49. Meissner, J. D., Freund, R., Krone, D., Umeda, P. K., Chang, K.-C., Gros, G., and Scheibe, R. J. (2011) Extracellular signalregulated kinase 1/2-mediated phosphorylation of p300 enhances myosin heavy chain I/beta gene expression via acetylation of nuclear factor of activated T cells c1. Nucleic Acids Res. 39, 5907-5925
50. Zhang, Y., Qiu, J., Wang, X., Zhang, Y., and Xia, M. (2011) AMP-activated protein kinase suppresses endothelial cell inflammation through phosphorylation of transcriptional coactivator p300. Arterioscler. Thromb. Vasc. Biol. 31, 2897-2908
51. Belmadani, S., Zerfaoui, M., Boulares, H. A., Palen, D. I., and Matrougui, K. (2008) Microvessel vascular smooth muscle cells contribute to collagen type I deposition through ERK1/2 MAP kinase, alphavbeta3-integrin, and TGF-beta1 in response to ANG II and high glucose. Am. J. Physiol. Heart Circ. Physiol. 295, 69-76
52. Cai, W., and Chen, X. (2006) Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism. Anticancer Agents Med. Chem. 6, 407-428
53. Lin, H. Y., Martino, L. J., Wilcox, B. D., Davis, F. B., Gordinier, J. K., and Davis, P. J. (1998) Potentiation by thyroid hormone of human IFN-γ-induced HLA-DR expression. J. Immunol. 161, 843-849